financetom
Business
financetom
/
Business
/
Enphase Energy Stock Is Getting Crushed Today: Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enphase Energy Stock Is Getting Crushed Today: Here's Why
Oct 29, 2025 10:52 AM

Enphase Energy Inc ( ENPH ) shares are sliding Wednesday after the company issued fourth-quarter revenue guidance below analyst expectations.

ENPH shares are retreating from recent levels. See what is happening here.

What Happened: Enphase reported financial results for the third quarter of 2025 that topped expectations, but guidance is weighing on shares on Wednesday.

Enphase said it expects fourth-quarter revenue between $310 million and $350 million, versus estimates of $381.44 million. The outlook excludes safe harbor shipments, which helped boost the company’s third-quarter’s results.

The company also guided for fourth-quarter gross margin between 40% and 43%, or 42% to 45% on an adjusted basis.

The weaker guidance comes after Enphase reported a third-quarter revenue beat of $410.4 million ($365.81 million estimate), its highest level in two years. The company shipped approximately 1.77 million microinverters, or 784.6 megawatts DC, along with a record 195 megawatt hours of IQ Batteries during the quarter.

Enphase Energy ( ENPH ) posted adjusted earnings per share of 90 cents (65 cent estimate), and generated $5.9 million in free cash flow during the period.

Following the company’s quarterly results, JPMorgan analyst Mark Strouse maintained Enphase with a Neutral rating and lowered the price target from $40 to $37. RBC Capital maintained a Sector Perform rating and cut its price target from $33 to $31.

ENPH Price Action: According to Benzinga Pro, Enphase Energy ( ENPH ) shares are trading down 12.59% at $32.09 at the time of publication on Wednesday, marking one of the stock’s larger single-session moves. It has hit a high of $33.44 and a low of $31.26 during Wednesday’s session.

Volume is well above average with 16.7 million shares traded. The stock is sitting 5.5% above its 52-week low and is currently 15.1% below its 50-day moving average.

Read Next:

Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Image: Piotr Swat/Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Environmental services firm Enviri Q3 loss widens, cuts forecast
Environmental services firm Enviri Q3 loss widens, cuts forecast
Nov 10, 2025
Overview * Enviri ( NVRI ) Q3 revenue remains flat at $575 mln, adjusted EBITDA falls to $74 mln * Company reports $20 mln GAAP loss from continuing operations, up from $11 mln last year * Enviri ( NVRI ) amends credit agreement to enhance financial flexibility * Company lowers full-year outlook Outlook * Enviri ( NVRI ) expects 2025...
Omni-Lite Q3 revenue up 7% on fasteners growth
Omni-Lite Q3 revenue up 7% on fasteners growth
Nov 10, 2025
Overview * Omni-Lite Q3 fiscal 2025 revenue rises 7% yr/yr, driven by fasteners growth * Adjusted EBITDA for Q3 fiscal 2025 increases due to better margins and product mix * Company achieves historical high backlog with US$5.5 mln in bookings Outlook * Omni-Lite anticipates increased activity in eComp business by year-end and into 2026 * Company expects favorable pricing from...
Biopharma Roivant's Q2 income from operations misses
Biopharma Roivant's Q2 income from operations misses
Nov 10, 2025
Overview * Roivant Q2 revenue declines, missing analyst expectations for income from operations * Company maintains strong cash position of $4.4 bln, supporting cash runway into profitability * Brepocitinib Phase 3 study in dermatomyositis shows significant improvement over placebo Outlook * Roivant plans NDA filing for brepocitinib in DM in H1 2026 * Immunovant expects TED study results in H1...
Handheld analyzer maker 908 Devices Inc's Q3 revenue beats estimates
Handheld analyzer maker 908 Devices Inc's Q3 revenue beats estimates
Nov 10, 2025
Overview * 908 Devices ( MASS ) Q3 revenue decreases 4% yr/yr but beats analyst expectations * Adjusted EBITDA loss improves 53% quarter over quarter * Net loss for Q3 misses analyst estimates Outlook * Company expects full-year 2025 revenue between $54.0 mln and $56.0 mln * Company sees potential impact from U.S. Government shutdown on award timing Result Drivers...
Copyright 2023-2026 - www.financetom.com All Rights Reserved